Toronto General Hospital
Hospitals & Physicians Clinics · Canada · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
585 University Ave, Toronto, Ontario, M5...Phone Number
(416) 340-4800Revenue
$896.6 MillionIndustry
About Toronto General Hospital
Toronto General Hospital Org Chart
Associate Director - Kidney Transplant Studen...
Is Toronto General Hospital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Toronto General Hospital had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Toronto General Hospital has new funding data
Check out if Toronto General Hospital is spiking on competitors!
Product Launch: Get notified when Toronto General Hospital launches new products
Earning: See what the market has to say on Toronto General Hospital recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Toronto General Hospital
Check if Toronto General Hospital has recently received funding, and reach out quickly before it becomes old news!
Toronto General Hospital, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Toronto General Hospital is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Toronto General Hospital is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Toronto General Hospital.
Toronto General Hospital Tech Stack
A closer look at the technologies used by Toronto General Hospital
Toronto General Hospital News & Media
Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University Health Network (UHN) Research Ethics Board has granted approval for Toronto General Hospital to participate in the Company’s ongoing Phase II trial evaluating LSALT peptide for the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
Top Hospitals & Physicians Clinics Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Toronto General Hospital
The University of Toronto offers a prestigious Fellowship in Abdominal Organ Transplantation, focusing on training future leaders in transplantation and hepatopancreatobiliary (HPB) surgery. The program provides a comprehensive clinical experience, integrating both transplant and HPB surgical tracks, with opportunities for complex procedures and re... Read More